Skip to main content
Erschienen in: Acta Neurochirurgica 11/2014

01.11.2014 | Clinical Article - Vascular

Collateralization and ischemia in hemodynamic cerebrovascular insufficiency

verfasst von: Marcus Czabanka, Gueliz Acker, Daniel Jussen, Tobias Finger, Pablo Pena-Tapia, Gerrit A. Schubert, Johann Scharf, Peter Martus, Peter Schmiedek, Peter Vajkoczy

Erschienen in: Acta Neurochirurgica | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Moyamoya disease and atherosclerotic cerebrovascular occlusive disease lead to hemodynamic impairment of cerebral blood flow. One major differentiation between both disease entities lies in the collateralization pathways. The clinical implications of the collateralization pathways for the development of hemodynamic ischemia remain unknown. The aim was to characterize collateralization and ischemia patterns in patients with chronic hemodynamic compromise.

Methods

Hemodynamic compromise was verified using acetazolamide-stimulated xenon-CT or SPECT in 54 patients [30 moyamoya and 24 atherosclerotic cerebrovascular disease (ACVD)]. All patients received MRI to differentiate hemodynamic ischemia into anterior/posterior cortical border zone infarction (CBI), inferior border zone infarction (IBI) or territorial infarction (TI). Digital subtraction angiography was applied to evaluate collateralization. Collateralization was compared and correlated with the localization of ischemia and number of vascular territories with impaired cerebrovascular reserve capacity (CVRC).

Results

MM patients showed collateralization significantly more often via pericallosal anastomosis and the posterior communicating artery (flow in the anterior-posterior direction; MM: 95 %/95 % vs. ACVD: 23 %/12 %, p < 0.05). ACVD patients demonstrated collateralization via the anterior and posterior communicating arteries (flow in the posterior-anterior direction, MM: 6 %/5 % vs. ACVD: 62 %/88 %, p < 0.05). Patterns of infarction were comparable (aCBI: MM: 36 % vs. ACVD: 35 %; pCBI: MM: 10 % vs. ACVD: 20 %; IBI: MM: 35 % vs. ACVD: 41 %; TI: MM: 13 % vs. ACVD: 18 %). The number and localization of vascular territories with impaired CVRC were comparable.

Conclusions

Despite significant differences in collateralization, the infarct patterns and severity of CVRC impairment do not differ between MMV and ACVD patients. Cerebral collateralization does not allow reaching conclusions about the localization of cerebral ischemia or severity of impaired CVRC in chronic hemodynamic impairment.
Literatur
1.
Zurück zum Zitat Campbell BC, Christensen S, Tress BM, Churilov L, Desmond PM, Parsons MW, Barber PA, Levi CR, Bladin C, Donnan GA, Davis SM (2013) Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab 33:1168–1172PubMedCrossRefPubMedCentral Campbell BC, Christensen S, Tress BM, Churilov L, Desmond PM, Parsons MW, Barber PA, Levi CR, Bladin C, Donnan GA, Davis SM (2013) Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab 33:1168–1172PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993–1003PubMedCrossRefPubMedCentral Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993–1003PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Conklin J, Fierstra J, Crawley AP, Han JS, Poublanc J, Silver FL, Tymianski M, Fisher JA, Mandell DM, Mikulis DJ (2011) Mapping white matter diffusion and cerebrovascular reactivity in carotid occlusive disease. Neurology 77:431–438PubMedCrossRef Conklin J, Fierstra J, Crawley AP, Han JS, Poublanc J, Silver FL, Tymianski M, Fisher JA, Mandell DM, Mikulis DJ (2011) Mapping white matter diffusion and cerebrovascular reactivity in carotid occlusive disease. Neurology 77:431–438PubMedCrossRef
4.
Zurück zum Zitat Czabanka M, Pena-Tapia P, Scharf J, Schubert GA, Munch E, Horn P, Schmiedek P, Vajkoczy P (2011) Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease. Cerebrovasc Dis 32:361–369PubMedCrossRef Czabanka M, Pena-Tapia P, Scharf J, Schubert GA, Munch E, Horn P, Schmiedek P, Vajkoczy P (2011) Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease. Cerebrovasc Dis 32:361–369PubMedCrossRef
5.
Zurück zum Zitat Czabanka M, Pena-Tapia P, Schubert GA, Woitzik J, Horn P, Schmiedek P, Vajkoczy P (2009) Clinical implications of cortical microvasculature in adult moyamoya disease. J Cereb Blood Flow Metab 29:1383–1387PubMedCrossRef Czabanka M, Pena-Tapia P, Schubert GA, Woitzik J, Horn P, Schmiedek P, Vajkoczy P (2009) Clinical implications of cortical microvasculature in adult moyamoya disease. J Cereb Blood Flow Metab 29:1383–1387PubMedCrossRef
6.
Zurück zum Zitat Czabanka M, Pena-Tapia P, Schubert GA, Woitzik J, Vajkoczy P, Schmiedek P (2008) Characterization of cortical microvascularization in adult moyamoya disease. Stroke 39:1703–1709PubMedCrossRef Czabanka M, Pena-Tapia P, Schubert GA, Woitzik J, Vajkoczy P, Schmiedek P (2008) Characterization of cortical microvascularization in adult moyamoya disease. Stroke 39:1703–1709PubMedCrossRef
7.
Zurück zum Zitat Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL, Jr., Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ (2013) Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL, Jr., Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ (2013) Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet
8.
Zurück zum Zitat Forster A, Szabo K, Hennerici MG (2008) Pathophysiological concepts of stroke in hemodynamic risk zones—do hypoperfusion and embolism interact? Nat Clin Pract Neurol 4:216–225PubMedCrossRef Forster A, Szabo K, Hennerici MG (2008) Pathophysiological concepts of stroke in hemodynamic risk zones—do hypoperfusion and embolism interact? Nat Clin Pract Neurol 4:216–225PubMedCrossRef
9.
Zurück zum Zitat Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240PubMedCrossRef Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240PubMedCrossRef
10.
Zurück zum Zitat Grubb RL Jr, Powers WJ, Clarke WR, Videen TO, Adams HP Jr, Derdeyn CP (2013) Surgical results of the carotid occlusion surgery study. J Neurosurg 118:25–33PubMedCrossRef Grubb RL Jr, Powers WJ, Clarke WR, Videen TO, Adams HP Jr, Derdeyn CP (2013) Surgical results of the carotid occlusion surgery study. J Neurosurg 118:25–33PubMedCrossRef
11.
Zurück zum Zitat Hecht N, He J, Kremenetskaia I, Nieminen M, Vajkoczy P, Woitzik J (2012) Cerebral hemodynamic reserve and vascular remodeling in C57/BL6 mice are influenced by age. Stroke 43:3052–3062PubMedCrossRef Hecht N, He J, Kremenetskaia I, Nieminen M, Vajkoczy P, Woitzik J (2012) Cerebral hemodynamic reserve and vascular remodeling in C57/BL6 mice are influenced by age. Stroke 43:3052–3062PubMedCrossRef
12.
14.
Zurück zum Zitat Liebeskind DS (2012) Collateral perfusion: time for novel paradigms in cerebral ischemia. Int J Stroke 7:309–310PubMedPubMedCentral Liebeskind DS (2012) Collateral perfusion: time for novel paradigms in cerebral ischemia. Int J Stroke 7:309–310PubMedPubMedCentral
15.
Zurück zum Zitat Liebeskind DS (2005) Location, location, location: angiography discerns early MR imaging vessel signs due to proximal arterial occlusion and distal collateral flow. AJNR Am J Neuroradiol 26:2432–2433, author reply 2433–4PubMed Liebeskind DS (2005) Location, location, location: angiography discerns early MR imaging vessel signs due to proximal arterial occlusion and distal collateral flow. AJNR Am J Neuroradiol 26:2432–2433, author reply 2433–4PubMed
16.
Zurück zum Zitat Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Cloft HJ, Chimowitz MI (2011) Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab 31:1293–1301PubMedCrossRefPubMedCentral Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Cloft HJ, Chimowitz MI (2011) Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab 31:1293–1301PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Moossy J (1993) Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke 24(I22–3):I31–I32 Moossy J (1993) Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke 24(I22–3):I31–I32
18.
Zurück zum Zitat Mugikura S, Takahashi S, Higano S, Shirane R, Kurihara N, Furuta S, Ezura M, Takahashi A (1999) The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol 20:336–343PubMed Mugikura S, Takahashi S, Higano S, Shirane R, Kurihara N, Furuta S, Ezura M, Takahashi A (1999) The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol 20:336–343PubMed
19.
Zurück zum Zitat Rafat N, Beck G, Pena-Tapia PG, Schmiedek P, Vajkoczy P (2009) Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke 40:432–438PubMedCrossRef Rafat N, Beck G, Pena-Tapia PG, Schmiedek P, Vajkoczy P (2009) Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke 40:432–438PubMedCrossRef
20.
Zurück zum Zitat Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhupl K (1994) Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg 81:236–244PubMedCrossRef Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhupl K (1994) Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg 81:236–244PubMedCrossRef
21.
Zurück zum Zitat Schubert GA, Czabanka M, Seiz M, Horn P, Vajkoczy P, Thome C (2014) Perfusion characteristics of moyamoya disease: an anatomically and clinically oriented analysis and comparison. Stroke 45:101–106PubMedCrossRef Schubert GA, Czabanka M, Seiz M, Horn P, Vajkoczy P, Thome C (2014) Perfusion characteristics of moyamoya disease: an anatomically and clinically oriented analysis and comparison. Stroke 45:101–106PubMedCrossRef
22.
Zurück zum Zitat Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237PubMedCrossRef Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237PubMedCrossRef
23.
Zurück zum Zitat Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS (2011) Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol 10:909–921PubMedCrossRef Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS (2011) Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol 10:909–921PubMedCrossRef
24.
Zurück zum Zitat Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRef Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRef
25.
Zurück zum Zitat Ture U, Yasargil MG, Krisht AF (1996) The arteries of the corpus callosum: a microsurgical anatomic study. Neurosurgery 39:1075–1084, discussion 1084–5PubMedCrossRef Ture U, Yasargil MG, Krisht AF (1996) The arteries of the corpus callosum: a microsurgical anatomic study. Neurosurgery 39:1075–1084, discussion 1084–5PubMedCrossRef
26.
Metadaten
Titel
Collateralization and ischemia in hemodynamic cerebrovascular insufficiency
verfasst von
Marcus Czabanka
Gueliz Acker
Daniel Jussen
Tobias Finger
Pablo Pena-Tapia
Gerrit A. Schubert
Johann Scharf
Peter Martus
Peter Schmiedek
Peter Vajkoczy
Publikationsdatum
01.11.2014
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 11/2014
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-014-2227-1

Weitere Artikel der Ausgabe 11/2014

Acta Neurochirurgica 11/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.